PHARMACYTE BIOTECH, INC. Financing Cash Flow
PHARMACYTE BIOTECH, INC. (PMCB) reported Financing Cash Flow of -$83.40 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) financing activities for the quarter ending 2026-07-31 was -$83.40K.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) financing activities for the quarter ending 2026-04-30 was -$169.82K.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) financing activities for the quarter ending 2026-01-31 was $543.78K.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) financing activities for the quarter ending 2025-10-31 was $6.21M.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) financing activities for fiscal 2026 was $6.58M.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) financing activities for fiscal 2025 was -$25.03M.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) financing activities for fiscal 2024 was -$10.71M.
- PHARMACYTE BIOTECH, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$13.56M, a 115.53% decline from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-07-31 | -$83.40K 10-Q · filed 2026-09-14 | -$253.22K derived: sum of 2 quarters · filed 2026-09-14 | $290.56K derived: sum of 3 quarters · filed 2026-09-14 | $6.50M derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-04-30 | -$169.82K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | $373.96K derived: sum of 2 quarters · filed 2026-07-29 | $6.58M derived: sum of 3 quarters · filed 2026-07-29 | $6.58M 10-K · filed 2026-07-29 |
| 2026-01-31 | $543.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | $6.75M derived: sum of 2 quarters · filed 2026-03-17 | $6.75M 10-Q · filed 2026-03-17 | $6.58M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-10-31 | $6.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-18 | $6.21M 10-Q · filed 2025-12-18 | $6.04M derived: sum of 3 quarters · filed 2026-09-14 | $2.09M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-07-31 | $0.00 10-Q · filed 2026-09-14 | -$171.54K derived: sum of 2 quarters · filed 2026-09-14 | -$4.12M derived: sum of 3 quarters · filed 2026-09-14 | -$14.86M derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-04-30 | -$171.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | -$4.12M derived: sum of 2 quarters · filed 2026-07-29 | -$14.86M derived: sum of 3 quarters · filed 2026-07-29 | -$25.03M 10-K · filed 2026-07-29 |
| 2025-01-31 | -$3.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-03-17 | -$14.69M derived: sum of 2 quarters · filed 2026-03-17 | -$24.86M 10-Q · filed 2026-03-17 | -$35.55M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-10-31 | -$10.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-12-18 | -$20.91M 10-Q · filed 2025-12-18 | -$31.61M derived: sum of 3 quarters · filed 2025-12-18 | -$38.65M derived: sum of 4 quarters · filed 2025-12-18 |
| 2024-07-31 | -$10.17M 10-Q · filed 2025-09-15 | -$20.87M derived: sum of 2 quarters · filed 2025-09-15 | -$27.91M derived: sum of 3 quarters · filed 2025-09-15 | -$27.16M derived: sum of 4 quarters · filed 2025-09-15 |
| 2024-04-30 | -$10.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | -$17.74M derived: sum of 2 quarters · filed 2025-08-11 | -$16.99M derived: sum of 3 quarters · filed 2025-08-11 | -$10.71M 10-K · filed 2025-08-11 |
| 2024-01-31 | -$7.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-03-17 | -$6.29M derived: sum of 2 quarters · filed 2025-03-17 | -$11.04K 10-Q · filed 2025-03-17 | -$4.32M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-10-31 | $748.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-12-13 | $7.03M 10-Q · filed 2024-12-13 | $2.72M derived: sum of 3 quarters · filed 2024-12-13 | -$1.06M derived: sum of 4 quarters · filed 2024-12-13 |
| 2023-07-31 | $6.28M 10-Q · filed 2024-09-17 | $1.97M derived: sum of 2 quarters · filed 2024-09-17 | -$1.81M derived: sum of 3 quarters · filed 2024-09-17 | -$5.19M derived: sum of 4 quarters · filed 2024-09-17 |
| 2023-04-30 | -$4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-13 | -$8.08M derived: sum of 2 quarters · filed 2024-08-13 | -$11.47M derived: sum of 3 quarters · filed 2024-08-13 | -$13.56M 10-K · filed 2024-08-13 |
| 2023-01-31 | -$3.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-03-18 | -$7.16M derived: sum of 2 quarters · filed 2024-03-18 | -$9.25M 10-Q · filed 2024-03-18 | -$9.30M derived: sum of 4 quarters · filed 2024-03-18 |
| 2022-10-31 | -$3.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-12-15 | -$5.48M 10-Q · filed 2023-12-15 | -$5.53M derived: sum of 3 quarters · filed 2023-12-15 | -$5.53M derived: sum of 4 quarters · filed 2023-12-15 |
| 2022-07-31 | -$2.09M 10-Q · filed 2023-09-18 | -$2.14M derived: sum of 2 quarters · filed 2023-09-18 | -$2.14M derived: sum of 3 quarters · filed 2023-09-18 | $85.22M derived: sum of 4 quarters · filed 2023-09-18 |
| 2022-04-30 | -$50.80K derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | -$50.80K derived: sum of 2 quarters · filed 2023-07-31 | $87.31M derived: sum of 3 quarters · filed 2023-07-31 | $87.31M 10-K · filed 2023-07-31 |
| 2022-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-03-16 | $87.36M derived: sum of 2 quarters · filed 2023-03-16 | $87.36M 10-Q · filed 2023-03-16 | $87.41M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-10-31 | $87.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-12-14 | $87.36M 10-Q · filed 2022-12-14 | $87.41M derived: sum of 3 quarters · filed 2022-12-14 | $87.37M derived: sum of 4 quarters · filed 2022-12-14 |
| 2021-07-31 | $0.00 10-Q · filed 2022-09-14 | $50.80K derived: sum of 2 quarters · filed 2022-09-14 | $12.64K derived: sum of 3 quarters · filed 2022-09-14 | $2.82M derived: sum of 4 quarters · filed 2022-09-14 |
| 2021-04-30 | $50.80K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | $12.64K derived: sum of 2 quarters · filed 2022-07-28 | $2.82M derived: sum of 3 quarters · filed 2022-07-28 | $4.64M 10-K · filed 2022-07-28 |
| 2021-01-31 | -$38.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-03-15 | $2.77M derived: sum of 2 quarters · filed 2022-03-15 | $4.59M 10-Q · filed 2022-03-15 | $5.98M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-10-31 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-12-14 | $4.62M 10-Q · filed 2021-12-14 | $6.02M derived: sum of 3 quarters · filed 2021-12-14 | $6.47M derived: sum of 4 quarters · filed 2021-12-14 |
| 2020-07-31 | $1.82M 10-Q · filed 2021-09-14 | $3.21M derived: sum of 2 quarters · filed 2021-09-14 | $3.66M derived: sum of 3 quarters · filed 2021-09-14 | $3.96M derived: sum of 4 quarters · filed 2021-09-14 |
| 2020-04-30 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-10 | $1.84M derived: sum of 2 quarters · filed 2021-08-10 | $2.14M derived: sum of 3 quarters · filed 2021-08-10 | $2.73M 10-K · filed 2021-08-10 |
| 2020-01-31 | $450.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-12 | $751.00K derived: sum of 2 quarters · filed 2021-03-12 | $1.33M 10-Q · filed 2021-03-12 | $1.82M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-10-31 | $301.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-12-11 | $883.50K 10-Q · filed 2020-12-11 | $1.37M derived: sum of 3 quarters · filed 2020-12-11 | $1.83M derived: sum of 4 quarters · filed 2020-12-11 |
| 2019-07-31 | $582.50K 10-Q · filed 2020-09-11 | $1.06M derived: sum of 2 quarters · filed 2020-09-11 | $1.53M derived: sum of 3 quarters · filed 2020-09-11 | $1.53M derived: sum of 4 quarters · filed 2020-09-11 |
| 2019-04-30 | $482.50K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | $947.50K derived: sum of 2 quarters · filed 2020-08-13 | $947.50K derived: sum of 3 quarters · filed 2020-08-13 | $2.34M 10-K · filed 2020-08-13 |
| 2019-01-31 | $465.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-03-13 | $465.00K derived: sum of 2 quarters · filed 2020-03-13 | $1.86M 10-Q · filed 2020-03-13 | $2.79M derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-12-23 | $1.40M 10-Q · filed 2019-12-23 | $2.33M derived: sum of 3 quarters · filed 2019-12-23 | $2.33M derived: sum of 4 quarters · filed 2019-12-23 |
| 2018-07-31 | $1.40M 10-Q · filed 2019-09-13 | $2.33M derived: sum of 2 quarters · filed 2019-09-13 | $2.33M derived: sum of 3 quarters · filed 2019-09-13 | $2.33M derived: sum of 4 quarters · filed 2019-09-13 |
| 2018-04-30 | $930.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | $930.00K derived: sum of 2 quarters · filed 2019-08-13 | $930.00K derived: sum of 3 quarters · filed 2019-08-13 | $2.68M 10-K · filed 2019-08-13 |
| 2018-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-03-14 | $0.00 derived: sum of 2 quarters · filed 2019-03-14 | $1.75M 10-Q · filed 2019-03-14 | $3.55M derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-12-14 | $1.75M 10-Q · filed 2018-12-14 | $3.55M derived: sum of 3 quarters · filed 2018-12-14 | $5.39M derived: sum of 4 quarters · filed 2018-12-14 |
| 2017-07-31 | $1.75M 10-Q · filed 2018-09-12 | $3.55M derived: sum of 2 quarters · filed 2018-09-12 | $5.39M derived: sum of 3 quarters · filed 2018-09-12 | $5.31M derived: sum of 4 quarters · filed 2018-09-12 |
| 2017-04-30 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-20 | $3.64M derived: sum of 2 quarters · filed 2018-07-20 | $3.56M derived: sum of 3 quarters · filed 2018-07-20 | $4.88M 10-K · filed 2018-07-20 |
| 2017-01-31 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-03-19 | $1.76M derived: sum of 2 quarters · filed 2018-03-19 | $3.08M 10-Q · filed 2018-03-19 | |
| 2016-10-31 | -$82.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-12-14 | $1.24M 10-Q · filed 2017-12-14 | ||
| 2016-07-31 | $1.33M 10-Q · filed 2017-09-13 | |||
| 2013-10-31 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | $3.12M 10-Q · filed 2013-12-16 | $3.59M derived: sum of 3 quarters · filed 2013-12-16 | $3.84M derived: sum of 4 quarters · filed 2013-12-16 |
| 2013-07-31 | $1.74M 10-Q · filed 2013-09-16 | $2.21M derived: sum of 2 quarters · filed 2013-09-16 | $2.46M derived: sum of 3 quarters · filed 2013-09-16 | $2.67M derived: sum of 4 quarters · filed 2013-12-16 |
| 2013-04-30 | $473.92K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $722.15K derived: sum of 2 quarters · filed 2013-07-29 | $931.00K derived: sum of 3 quarters · filed 2013-12-16 | $1.22M 10-K · filed 2013-07-29 |
| 2013-01-31 | $248.23K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | $457.08K derived: sum of 2 quarters · filed 2013-12-16 | $746.84K 10-Q · filed 2013-03-26 | $967.17K derived: sum of 4 quarters · filed 2013-12-16 |
| 2012-10-31 | $208.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-16 | $498.60K 10-Q · filed 2013-12-16 | $718.93K derived: sum of 3 quarters · filed 2013-12-16 | $899.64K derived: sum of 4 quarters · filed 2013-12-16 |
| 2012-07-31 | $289.76K 10-Q · filed 2013-09-16 | $510.09K derived: sum of 2 quarters · filed 2013-09-16 | $690.80K derived: sum of 3 quarters · filed 2013-09-16 | $913.80K derived: sum of 4 quarters · filed 2013-09-16 |
| 2012-04-30 | $220.33K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | $401.04K derived: sum of 2 quarters · filed 2013-07-29 | $624.04K derived: sum of 3 quarters · filed 2013-07-29 | $1.09M 10-K · filed 2013-07-29 |
| 2012-01-31 | $180.71K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-26 | $403.71K derived: sum of 2 quarters · filed 2013-03-26 | $869.21K 10-Q · filed 2013-03-26 | $1.06M derived: sum of 4 quarters · filed 2013-03-26 |
| 2011-10-31 | $223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-26 | $688.50K 10-Q · filed 2012-12-26 | $883.96K derived: sum of 3 quarters · filed 2012-12-26 | $956.49K derived: sum of 4 quarters · filed 2012-12-26 |
| 2011-07-31 | $465.50K 10-Q · filed 2012-09-19 | $660.96K derived: sum of 2 quarters · filed 2012-09-19 | $733.49K derived: sum of 3 quarters · filed 2012-09-19 | $734.22K derived: sum of 4 quarters · filed 2012-09-19 |
| 2011-04-30 | $195.46K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | $267.99K derived: sum of 2 quarters · filed 2012-08-14 | $268.72K derived: sum of 3 quarters · filed 2012-08-14 | $281.72K 10-K · filed 2012-08-14 |
| 2011-01-31 | $72.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-21 | $73.26K derived: sum of 2 quarters · filed 2012-03-21 | $86.26K 10-Q · filed 2012-03-21 | |
| 2010-10-31 | $729.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2011-12-15 | $13.73K 10-Q · filed 2011-12-15 | ||
| 2010-07-31 | $13.00K 10-Q/A · filed 2011-09-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |